Cell Therapeutics Inc. Newsletter
-
NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit
06 Aug 2025 12:00 GMT
… and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y … innovative autologous and allogeneic NK cell therapeutics. NKGen is headquartered in Santa …
-
Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement
18 Jul 2025 09:45 GMT
BrainStorm Cell Therapeutics Inc. BCLI shares crashed 42. … Kicks In
CEO of BrainStorm Cell Therapeutics, Chaim Lebovits, on the company … Edge Stock Rankings indicate BrainStorm Cell Therapeutics has a positive short-term …
-
BrainStorm Cell Therapeutics Crashes After Hours On Nasdaq Delisting Notice; Retail Sees 'Buy Time'
18 Jul 2025 06:09 GMT
Shares of BrainStorm Cell Therapeutics slipped in after-hours trading …
-
BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB
17 Jul 2025 21:04 GMT
… Lebovits, CEO of BrainStorm Cell Therapeutics, stated, "While … progression.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. (NASDAQ: … news-releases/brainstorm-cell-therapeutics-announces-nasdaq-delisting-and …
-
Natural Killer Cell Therapeutics Market
04 Jul 2025 18:11 GMT
… T-cell receptor (TCR) NK cell therapeutics, leveraging proprietary technologies from both … type, the natural killer cell therapeutics market is segmented into allogeneic … Strategy with Our Natural Killer Cell Therapeutics Market Insights –
• Download the …
-
Lineage Cell Therapeutics unveils promising Phase I/IIa OpRegen results at CTS 2025
02 Jul 2025 13:43 GMT
Lineage Cell Therapeutics recently revealed the results of … /IIa trial. Should Lineage Cell Therapeutics’ Phase II trial for OpRegen …
-
Gene and Cell Therapies Targeting CNS Disorders Market Research 2025-2035 | Novartis, BrainStorm Cell Therapeutics, Neuroplast, Rapa Therapeutics, and Longeveron Driving Innovations - ResearchAndMarkets.com
27 Jun 2025 13:42 GMT
… , such as Novartis, and BrainStorm Cell Therapeutics are continuously innovating to improve … .
Companies Featured
Novartis AG
BrainStorm Cell Therapeutics
Neuroplast
Rapa Therapeutics
Longeveron
Key …
-
In-Depth Analysis Of The Global Natural Killer Nk Cell Therapeutics Market: Key Drivers, Trends, And Forecast 2025-2034
20 Jun 2025 12:39 GMT
… The Global Natural Killer NK Cell Therapeutics Market Growth?
The rising … NK Cell Therapeutics Market?
Prominent players in the natural killer NK cell therapeutics … Killer NK Cell Therapeutics Market?
The natural killer NK cell therapeutics market is …
-
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
05 Jun 2025 12:16 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … $5 million.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage …
-
Preclinical Models Of Immune Oncology For CART-Cell Therapeutics Development
28 May 2025 21:00 GMT
… Chimeric Antigen Receptor (CAR) T cell therapeutics, and potent antibody-drug conjugates …
About
© 1995-2025